Von Willebrand Disease (VWD)
Part 1: NHLBI Diagnosis Guidelines
Introduction & Clinical Assessment Recommendations
May 2011
Von Willebrand disease (VWD) is a commonly encountered inherited bleeding disorder that affects both males and females. It may also occur less frequently as an acquired disorder (acquired von Willebrand syndrome: AVWS). A published evidence-based guideline from the National Heart, Lung, and Blood Institute (NHLBI) expert panel outlines recommendations for the evaluation and management of VWD, including suggesting an approach for clinical and laboratory evaluation of individuals with bleeding symptoms, history of bleeding or conditions associated with increased bleeding risk.
This is the first in a four-part series on von Willebrand disease.
Presenter:
Print Options
- Before viewing, print the Notes Pages.
- After viewing, obtain a Record of Viewing.
The von Willebrand Disease (VWD) Series
- Hot Topic: Von Willebrand Disease (VWD) Part 1: NHLBI Diagnosis Guidelines
- Hot Topic: Von Willebrand Disease (VWD) Part 2: NHLBI Diagnosis Guidelines
- Hot Topic: Von Willebrand Disease (VWD) Part 3: VWF Activity Assay
- Hot Topic: Von Willebrand Disease (VWD) Part 4: VWF Multimer Analysis
Related Tests
- von Willebrand Profile
- von Willebrand Factor Multimer Analysis, Plasma
- von Willebrand Factor Antigen, Plasma
- von Willebrand Factor Activity, Plasma
- Coagulation Factor VIII Activity Assay, Plasma
- von Willebrand Disease 2N (Subtype Normandy), Blood
Forward to a Colleague
Share this presentation with:
- Hematologists
- Coagulationists
- Cardiologists
If you have questions, e-mail
External
link
PDF
document
Excel
document
Word
document